Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries

According to population-based studies, lung cancer is the prominent reason for cancer-related mortality worldwide in males and is also rising in females at an alarming rate. Sorafenib (SOR), which is approved for the treatment of hepatocellular carcinoma and renal cell carcinoma, is a multitargeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicek, Betul, Hacimuftuoglu, Ahmet, Kuzucu, Mehmet, Cetin, Ahmet, Yeni, Yesim, Genc, Sidika, Yildirim, Serkan, Bolat, Ismail, Kantarci, Mecit, Gul, Mustafa, Hayme, Serhat, Matthaios, Dimitris, Vageli, Dimitra P., Doukas, Sotirios G., Tsatsakis, Aristidis, Taghizadehghalehjoughi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963576/
https://www.ncbi.nlm.nih.gov/pubmed/37259369
http://dx.doi.org/10.3390/ph16020221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963576/
https://www.ncbi.nlm.nih.gov/pubmed/37259369
http://dx.doi.org/10.3390/ph16020221

Ejemplares similares